UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 30, 2022
Accession Number:
0001104659-22-104261
Submission Type:
POS AM
CIK:
0001729214
Company Name:
XORTX Therapeutics Inc.
File Number:
333-267328